Pharmacogenetic study of the effects of raloxifene on negative symptoms of postmenopausal women with schizophrenia: A double-blind, randomized, placebo-controlled trial-Reference-Cited by-同舟云学术

Pharmacogenetic study of the effects of raloxifene on negative symptoms of postmenopausal women with schizophrenia: A double-blind, randomized, placebo-controlled trial

Published:2016-10 Issue:10 Volume:26 Page:1683-1689
ISSN:0924-977X
Container-title:European Neuropsychopharmacology
language:en
Short-container-title:European Neuropsychopharmacology

Author:

Labad Javier,Martorell Lourdes,Huerta-Ramos Elena,Cobo Jesús,Vilella Elisabet,Rubio-Abadal Elena,Garcia-Pares Gemma,Creus Marta,Núñez Cristian,Ortega Laura,Miquel Eva,Usall Judith

Publisher

Elsevier BV

Subject

Pharmacology (medical),Biological Psychiatry,Psychiatry and Mental health,Neurology (clinical),Neurology,Pharmacology

Reference25 articles.

1. Adjusting for multiple testing - When and how?;Bender;J. Clin. Epidemiol.,2001

2. Clinical Gynecology;Bieber,2006

3. Breast cancer after use of estrogen plus progestin in postmenopausal women;Chlebowski;N. Engl. J. Med.,2009

4. Neuroprotective actions of selective estrogen receptor modulators;DonCarlos;Psychoneuroendocrinology,2009

5. International consensus study of antipsychotic dosing;Gardner;Am. J. Psychiatry,2010

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integrated Bioinformatics Analysis for the Screening of Hub Genes and Therapeutic Drugs in Androgen Receptor-Positive TNBC;Disease Markers;2022-09-14

2. Peri- and Post-Menopausal Women with Schizophrenia and Related Disorders Are a Population with Specific Needs: A Narrative Review of Current Theories;Journal of Personalized Medicine;2021-08-27

3. Estrogens in schizophrenia: progress, current challenges and opportunities;Current Opinion in Psychiatry;2021-02-04

4. Pharmacogenomics Study for Raloxifene in Postmenopausal Female with Osteoporosis;Disease Markers;2020-08-31

5. Antipsychotic-induced Hyperprolactinemia in aging populations: Prevalence, implications, prevention and management;Progress in Neuro-Psychopharmacology and Biological Psychiatry;2020-07